Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency

Clinical trial NCT01054339 · COMPLETED

Trial details

NCT number: NCT01054339
Sponsor: Beacon Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alpha-1 Antitrypsin Deficiency

Start date: 2010-06-01
Primary completion: 2011-10-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.